Three Biotechs on the FDA's December Calendar That Could Pop Before 2013

Published December 12, 2012

Three Biotechs On The FDA's December Calendar That Could Pop Before 2013

Filed under: drug addiction treatment act of 2000

Alexza Pharmaceuticals Inc's (ALXA) expects to hear from the FDA for its ADASUVE New Drug Application (NDA) with an indicated Prescription Drug User Fee Act (PDUFA) goal date of December 21, 2012. ADASUVE (Staccato loxapine) is Alexza's lead program …
Read more on iStockAnalyst

The Courts: How Obama Dropped the Ball

Filed under: drug addiction treatment act of 2000

… to counsel, upheld Virginia's mandatory parental notification law on abortions, overturned key portions of the Violence Against Woman Act and the Clean Water Act, denied Civil Rights Act remedies to workers subjected to racial epithets, and ruled …
Read more on The American Prospect

Pfizer Agrees to Pay Million for Illegally Promoting Protonix for Off …

Filed under: drug addiction treatment act of 2000

Pfizer Inc. will pay $ 55 million plus interest to resolve allegations that Wyeth LLC illegally introduced and caused the introduction into interstate commerce of a misbranded drug, Protonix, between February 2000 and June 2001, the Justice Department …
Read more on Equities.com